DOSSIER · 13F Holders · Q2 2026
NEWAMSTERDAM PHARMA COMPANY
3 institutions still hold NEWAMSTERDAM PHARMA COMPANY as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP N62509959·3 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
3 institutions reported NEWAMSTERDAM PHARMA COMPANY in Q2 2026. IMC-Chicago, LLC leads at 70.1% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.